HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

KR-31378 protects cardiac H9c2 cells from chemical hypoxia-induced cell death via inhibition of JNK/p38 MAPK activation.

Abstract
Using a metabolic inhibition buffer as an ischemic model, we show here that KR-31378, a cardioselective ATP-sensitive potassium channel opener, protects H9c2 cells from chemical hypoxia (CH)-induced cell death. Our previous study showed that CH downregulated caspase activities, but led to differential activation of mitogen-activated protein kinases (MAPKs) in H9c2 cells. The repression of CH-induced c-jun N-terminal kinase (JNK)/p38 MAPK activation resulted in partial protection against CH- induced cell death, implying JNK/p38 MAPK's causative role in CH-induced cell death. This study furthers that research and examines if KR-31378's protective effect came from modulating MAPK activity and/or caspase activity in H9c2 cells. Although KR-31378 did not restore downregulated caspase-3 activity, it did block the activation of JNK and p38 MAPK in a dose-dependent manner. Extracellular signal-regulated kinase activity was not recovered by KR-31378 treatment. CH-induced reactive oxygen species (ROS) generation was suppressed by KR-31378. Thus our results indicate that the cardioprotective effect of KR-31378 in CH is due, at least in part, to the differential inhibition of MAPKs.
AuthorsYong-Sam Jung, Dong-Ha Lee, Hong Lim, Kyu Yang Yi, Sung-Eun Yoo, Eunhee Kim
JournalThe Japanese journal of physiology (Jpn J Physiol) Vol. 54 Issue 6 Pg. 575-83 (Dec 2004) ISSN: 0021-521X [Print] Japan
PMID15760490 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anthracenes
  • Butadienes
  • Guanidines
  • Imidazoles
  • N''-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine
  • Nitriles
  • Pyrans
  • Pyridines
  • Reactive Oxygen Species
  • U 0126
  • pyrazolanthrone
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4
  • Mitogen-Activated Protein Kinase Kinases
  • SB 203580
Topics
  • Animals
  • Anthracenes (pharmacology)
  • Butadienes (pharmacology)
  • Cell Death (drug effects, physiology)
  • Cell Hypoxia (physiology)
  • Cell Line
  • Enzyme Activation (drug effects)
  • Guanidines (chemistry, pharmacology)
  • Imidazoles (pharmacology)
  • JNK Mitogen-Activated Protein Kinases (antagonists & inhibitors)
  • MAP Kinase Kinase 4
  • Mitogen-Activated Protein Kinase Kinases (antagonists & inhibitors)
  • Molecular Structure
  • Myocardium (cytology)
  • Nitriles (pharmacology)
  • Pyrans (chemistry, pharmacology)
  • Pyridines (pharmacology)
  • Reactive Oxygen Species
  • p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: